Jim Simons
NUVB icon

Jim Simons’s Nuvation Bio NUVB Stock Holding History

Jim Simons’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.4M Buy
+559,180
New +$3.12M ﹤0.01% 1808
2025
Q3 		– Sell
-22,100
Closed -$43.1K – 3776
2025
Q2 		$43.1K Sell
22,100
-422,000
-95% -$879K ﹤0.01% 3413
2025
Q1 		$782K Sell
444,100
-122,700
-22% -$279K ﹤0.01% 2549
2024
Q4 		$1.51M Sell
566,800
-462,200
-45% -$1.19M ﹤0.01% 2233
2024
Q3 		$2.36M Buy
1,029,000
+268,000
+35% +$817K ﹤0.01% 1910
2024
Q2 		$2.22M Sell
761,000
-213,700
-22% -$652K ﹤0.01% 1822
2024
Q1 		$3.55M Sell
974,700
-508,431
-34% -$976K 0.01% 1640
2023
Q4 		$2.24M Buy
1,483,131
+1,093,131
+280% +$1.41M ﹤0.01% 1879
2023
Q3 		$523K Buy
390,000
+78,100
+25% +$130K ﹤0.01% 2691
2023
Q2 		$561K Buy
311,900
+38,800
+14% +$66K ﹤0.01% 2812
2023
Q1 		$453K Buy
273,100
+128,900
+89% +$261K ﹤0.01% 2935
2022
Q4 		$277K Sell
144,200
-116,315
-45% -$235K ﹤0.01% 3261
2022
Q3 		$584K Buy
260,515
+174,215
+202% +$497K ﹤0.01% 2837
2022
Q2 		$280K Sell
86,300
-5,900
-6% -$25.7K ﹤0.01% 3494
2022
Q1 		$485K Buy
92,200
+42,600
+86% +$239K ﹤0.01% 3217
2021
Q4 		$422K Sell
49,600
-800
-2% -$7.35K ﹤0.01% 3159
2021
Q3 		$501K Sell
50,400
-416,400
-89% -$3.77M ﹤0.01% 2892
2021
Q2 		$4.35M Buy
+466,800
New +$5.32M 0.01% 1716

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jim Simons's NUVB Position: Q1 2026 in Review

Jim Simons opened a new position in Nuvation Bio (NUVB) in Q1 2026: 559,180 shares worth $2.4M. The stake represents ﹤0.01% of the portfolio and ranks #1808 among its holdings. This is a return to the name: Jim Simons previously reported a position in NUVB as recently as Q2 2025.

Jim Simons first reported a position in NUVB in Q2 2021 and has held it in 18 quarters since. The position peaked at $4.35M in Q2 2021. 233 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Jim Simons held 559,180 shares of Nuvation Bio worth $2.4M as of Q1 2026.
  • Nuvation Bio was a new Jim Simons position in Q1 2026.
  • Nuvation Bio made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #1808 holding.
  • Jim Simons first reported a position in Nuvation Bio in Q2 2021 and has held it in 18 quarters since.
  • Jim Simons's Nuvation Bio position peaked at $4.35M in Q2 2021.
  • 233 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.